A phase II, double-masked, randomized, placebo-controlled evaluation of a human monoclonal anti-Cytomegalovirus antibody (MSL-109) in combination with standard therapy versus standard therapy alone in the treatment of AIDS patients with Cytomegalovirus retinitis
Title:
A phase II, double-masked, randomized, placebo-controlled evaluation of a human monoclonal anti-Cytomegalovirus antibody (MSL-109) in combination with standard therapy versus standard therapy alone in the treatment of AIDS patients with Cytomegalovirus retinitis
Author:
Borucki, Michael J. Spritzler, John Asmuth, David M. Gnann, John Hirsch, Martin S. Nokta, Mostafa Aweeka, Francesca Nadler, Paul I. Sattler, Fred Alston, Beverly Nevin, Thomas T. Owens, Susan Waterman, Karen Hubbard, Larry Caliendo, Angela Pollard, Richard B.